Table 6. Number of 3-year survivors and 5-year survivors according to clinical factors.
Clinical factor | No. of patients | No. of 3-year survivors | No. of 5-year survivors |
---|---|---|---|
Total | 38 | 10 | 4 |
Surgical procedure | |||
Sublob. | 10 | 1 | 0 |
Over lob. | 28 | 9 | 4 |
EGFR mutation | |||
Positive | 6 | 2 | 1 |
Negative or unknown | 32 | 8 | 3 |
T status | |||
T1–2 | 20 | 3 | 2 |
T3–4 | 18 | 7 | 2 |
N status | |||
Negative | 16 | 6 | 3 |
Positive | 22 | 4 | 1 |
cM status | |||
cM0 | 11 | 5 | 2 |
cM1a | 8 | 0 | 0 |
cM1b | 13 | 4 | 1 |
cM1c | 6 | 1 | 1 |
Meta site | |||
With brain | 5 | 2 | 1 |
Without brain | 14 | 3 | 1 |
Local control | |||
Controlled | 13 | 5 | 2 |
Uncontrolled | 6 | 0 | 0 |
M category | |||
M better | 24 | 10 | 4 |
M worse | 14 | 0 | 0 |
Sublob, sublobar resection; lob., lobectomy; EGFR, epidermal growth factor receptor.